CY1117378T1 - INDIAZOLIS SUSPENSIONS TOY WNT SIGNIFICANT TRANSFER TRAFFIC AND THEIR THERAPEUTIC USES - Google Patents
INDIAZOLIS SUSPENSIONS TOY WNT SIGNIFICANT TRANSFER TRAFFIC AND THEIR THERAPEUTIC USESInfo
- Publication number
- CY1117378T1 CY1117378T1 CY20161100001T CY161100001T CY1117378T1 CY 1117378 T1 CY1117378 T1 CY 1117378T1 CY 20161100001 T CY20161100001 T CY 20161100001T CY 161100001 T CY161100001 T CY 161100001T CY 1117378 T1 CY1117378 T1 CY 1117378T1
- Authority
- CY
- Cyprus
- Prior art keywords
- wnt
- indiazolis
- toy
- suspensions
- therapeutic uses
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Γνωστοποιούνται ενώσεις ινδαζόλης για την αντιμετώπιση διαφόρων ασθενειών και παθολογιών. Πιο συγκεκριμένα, η παρούσα εφεύρεση αφορά τη χρήση μιας ένωσης ινδαζόλης ή αναλόγων της, στην αντιμετώπιση διαταραχών που χαρακτηρίζονται από την ενεργοποίηση του Wnt μονοπατιού μεταγωγής σήματος (π.χ., καρκίνων, ανώμαλου κυτταρικού πολλαπλασιασμού, αγγειογένεσης, νόσου Alzheimer's και οστεοαρθρίτιδας), τον συντονισμό κυτταρικών διεργασιών που ρυθμίζονται από το Wnt μεταγωγικό μονοπάτι, καθώς επίσης και από γενετικές ασθένειες που οφείλονται σε μεταλλάξεις των μεταγωγών του Wnt μονοπατιού. Επιπλέον, παρέχονται μέθοδοι για την αντιμετώπιση καταστάσεων ασθενειών που σχετίζονται με το Wnt μονοπάτι.Indazole compounds for the treatment of various diseases and pathologies are disclosed. More particularly, the present invention relates to the use of an indazole compound or analogs thereof in the treatment of disorders characterized by activation of the Wnt signal transduction pathway (e.g., cancers, abnormal cell proliferation, angiogenesis, Alzheimer's disease, and osteoarthritis). coordination of cellular processes regulated by the Wnt pathway, as well as by genetic diseases due to mutations in the Wnt pathway transitions. In addition, methods are provided to deal with disease states associated with the Wnt pathway.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23260309A | 2009-08-10 | 2009-08-10 | |
US30545910A | 2010-02-17 | 2010-02-17 | |
EP10808589.5A EP2464232B1 (en) | 2009-08-10 | 2010-08-09 | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117378T1 true CY1117378T1 (en) | 2017-04-26 |
Family
ID=58606615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100001T CY1117378T1 (en) | 2009-08-10 | 2016-01-04 | INDIAZOLIS SUSPENSIONS TOY WNT SIGNIFICANT TRANSFER TRAFFIC AND THEIR THERAPEUTIC USES |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1117378T1 (en) |
-
2016
- 2016-01-04 CY CY20161100001T patent/CY1117378T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119485T1 (en) | Indazole Suspensions of the WNT Signaling Pathway and Their Therapeutic Uses | |
CY1124302T1 (en) | ISOQUINOLIN-3-YL CARBOXAMIDES AND THEIR PREPARATION AND USE | |
CY1122795T1 (en) | INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS INHIBITORS OF THE WNT/B-CATENIN SIGNALING PATHWAY | |
CY1119194T1 (en) | INDOLO AND INDOZOLO COMPOUNDS ACTIVATING AMPK | |
MX2015008860A (en) | 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof. | |
CY1119123T1 (en) | BIS-ARYLOSYCLOSED ARYLOTRIAZOLONES AND THEIR USE | |
CY1117726T1 (en) | POSITIVE ALLOYSTERIC RETURNS M1 KINOLINAMIDE RECEPTORS | |
CY1118061T1 (en) | HETEROCYCLYL BICYCLE DERIVATIVES AS KINASE FGFR FOR THERAPEUTIC USE | |
CY1109104T1 (en) | 1,2,3,4 TETRA-SUBSTITUTE INDOLOGY FOR TREATMENT OF RESPIRATORY DISEASES | |
CY1117372T1 (en) | Substituted 5-fluoro-1H-pyrazolopyridines and their use | |
EA201071057A1 (en) | DERIVATIVES OF AZETIDINE AND CYCLUBUTAN AS JAK-KINAZ INHIBITORS | |
MA39763A (en) | 5-substituted indazole-3-carboxamides and preparation and use thereof | |
CY1116452T1 (en) | POSITIVE ALLOYSTELE REGULATORS M1 RECEPTORS OF PYRANYL ARYL Methyl Methyl Benzyl | |
CY1116057T1 (en) | KINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS RI3 | |
CY1111757T1 (en) | XANTHINI PRODUCTS AS ELECTRIC SUSPENSIONS HM74A | |
CY1116315T1 (en) | KINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS RI3 | |
CY1111702T1 (en) | INDOLO PRODUCERS AS S1P1 RECEPTOR RACE | |
EA201200952A1 (en) | DERIVATIVES OF PYRAZINE AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
CY1108347T1 (en) | IMIDAZOLI UNIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
EA201391106A1 (en) | NEW HETEROCYCLIC DERIVATIVES | |
EA201490888A1 (en) | NEW PURIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
EA201071144A1 (en) | HETEROCYCLIC DERIVATIVES | |
EA201270480A1 (en) | NEW CONNECTIONS | |
CU24087B1 (en) | CARBAZOL COMPOUNDS | |
EA200901042A1 (en) | DERIVATIVES 1-BENZULFONIL-1H-INDOL AS ACTIVITY INHIBITORS CCR9 |